BIOMAT Database Logo BIOMAT Database Logo

[Sensibility and specificity of N-myc oncogene with respect to other prognostic factors in 15 neuroblastomas]. 1995

A Queizán, and P García-Miguel, and M J Belló, and J C Castresana, and J A Rey, and A Pestaña
Departamento de Cirugía Pediátrica, Hospital Infantil La Paz, Madrid.

Several biologic features of tumor cells correlate closely with a favorable or unfavorable outcome. To aid in assessing correlation in the various number of prognostic factors including the age, stage, VMA/HVA ratios, and the serum levels of NSE and ferritin, the histopathological features, ploidy, partial monosomy for the short arm of chromosome 1, and the tumor N-myc gene copy number, are examined. We determined the sensitivity and specificity of classical markers above the amplification of the N-myc oncogene. A striking new observation is the positive correlation between genomic amplification and some prognostic factors (stage, ferritin, NSE, pathologic anatomy and 1p deletion.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D009447 Neuroblastoma A common neoplasm of early childhood arising from neural crest cells in the sympathetic nervous system, and characterized by diverse clinical behavior, ranging from spontaneous remission to rapid metastatic progression and death. This tumor is the most common intraabdominal malignancy of childhood, but it may also arise from thorax, neck, or rarely occur in the central nervous system. Histologic features include uniform round cells with hyperchromatic nuclei arranged in nests and separated by fibrovascular septa. Neuroblastomas may be associated with the opsoclonus-myoclonus syndrome. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2099-2101; Curr Opin Oncol 1998 Jan;10(1):43-51) Neuroblastomas
D009857 Oncogenes Genes whose gain-of-function alterations lead to NEOPLASTIC CELL TRANSFORMATION. They include, for example, genes for activators or stimulators of CELL PROLIFERATION such as growth factors, growth factor receptors, protein kinases, signal transducers, nuclear phosphoproteins, and transcription factors. A prefix of "v-" before oncogene symbols indicates oncogenes captured and transmitted by RETROVIRUSES; the prefix "c-" before the gene symbol of an oncogene indicates it is the cellular homolog (PROTO-ONCOGENES) of a v-oncogene. Transforming Genes,Oncogene,Transforming Gene,Gene, Transforming,Genes, Transforming
D011003 Ploidies The degree of replication of the chromosome set in the karyotype. Ploidy
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D001932 Brain Neoplasms Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain. Brain Cancer,Brain Metastases,Brain Tumors,Cancer of Brain,Malignant Primary Brain Tumors,Neoplasms, Intracranial,Benign Neoplasms, Brain,Brain Neoplasm, Primary,Brain Neoplasms, Benign,Brain Neoplasms, Malignant,Brain Neoplasms, Malignant, Primary,Brain Neoplasms, Primary Malignant,Brain Tumor, Primary,Brain Tumor, Recurrent,Cancer of the Brain,Intracranial Neoplasms,Malignant Neoplasms, Brain,Malignant Primary Brain Neoplasms,Neoplasms, Brain,Neoplasms, Brain, Benign,Neoplasms, Brain, Malignant,Neoplasms, Brain, Primary,Primary Brain Neoplasms,Primary Malignant Brain Neoplasms,Primary Malignant Brain Tumors,Benign Brain Neoplasm,Benign Brain Neoplasms,Benign Neoplasm, Brain,Brain Benign Neoplasm,Brain Benign Neoplasms,Brain Cancers,Brain Malignant Neoplasm,Brain Malignant Neoplasms,Brain Metastase,Brain Neoplasm,Brain Neoplasm, Benign,Brain Neoplasm, Malignant,Brain Neoplasms, Primary,Brain Tumor,Brain Tumors, Recurrent,Cancer, Brain,Intracranial Neoplasm,Malignant Brain Neoplasm,Malignant Brain Neoplasms,Malignant Neoplasm, Brain,Neoplasm, Brain,Neoplasm, Intracranial,Primary Brain Neoplasm,Primary Brain Tumor,Primary Brain Tumors,Recurrent Brain Tumor,Recurrent Brain Tumors,Tumor, Brain
D002872 Chromosome Deletion Actual loss of portion of a chromosome. Monosomy, Partial,Partial Monosomy,Deletion, Chromosome,Deletions, Chromosome,Monosomies, Partial,Partial Monosomies
D002878 Chromosomes, Human, Pair 1 A specific pair of human chromosomes in group A (CHROMOSOMES, HUMAN, 1-3) of the human chromosome classification. Chromosome 1

Related Publications

A Queizán, and P García-Miguel, and M J Belló, and J C Castresana, and J A Rey, and A Pestaña
[Amplification of oncogene N-myc in human neuroblastomas].
April 1987, Gan no rinsho. Japan journal of cancer clinics,
A Queizán, and P García-Miguel, and M J Belló, and J C Castresana, and J A Rey, and A Pestaña
Amplified allele of the human N-myc oncogene in neuroblastomas.
June 1988, Japanese journal of cancer research : Gann,
A Queizán, and P García-Miguel, and M J Belló, and J C Castresana, and J A Rey, and A Pestaña
Amplification of N-myc oncogene in stage II and IVS neuroblastomas may be a prognostic indicator.
May 1987, Journal of pediatric surgery,
A Queizán, and P García-Miguel, and M J Belló, and J C Castresana, and J A Rey, and A Pestaña
N-myc oncogene amplification and prognostic factors of neuroblastoma in children.
October 1987, Journal of pediatric surgery,
A Queizán, and P García-Miguel, and M J Belló, and J C Castresana, and J A Rey, and A Pestaña
Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas.
October 1985, The New England journal of medicine,
A Queizán, and P García-Miguel, and M J Belló, and J C Castresana, and J A Rey, and A Pestaña
Expression of N-myc by neuroblastomas with one or multiple copies of the oncogene.
January 1988, Progress in clinical and biological research,
A Queizán, and P García-Miguel, and M J Belló, and J C Castresana, and J A Rey, and A Pestaña
N-MYC overexpression and neuroblastomas.
October 2002, Trends in pharmacological sciences,
A Queizán, and P García-Miguel, and M J Belló, and J C Castresana, and J A Rey, and A Pestaña
Inverse correlation between expression of multidrug resistance gene and N-myc oncogene in human neuroblastomas.
May 1990, Cancer research,
A Queizán, and P García-Miguel, and M J Belló, and J C Castresana, and J A Rey, and A Pestaña
[Prognostic value of the N-myc oncogene in neuroblastoma].
January 1988, Bulletin du cancer,
A Queizán, and P García-Miguel, and M J Belló, and J C Castresana, and J A Rey, and A Pestaña
Single copies of the N-myc oncogene in neuroblastomas from children presenting with the syndrome of opsoclonus-myoclonus.
August 1988, Cancer,
Copied contents to your clipboard!